Direct-acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver-kidney transplant recipients
2019 ◽
Vol 20
(3)
◽
pp. 739-751
◽
2016 ◽
Vol 150
(4)
◽
pp. S1105-S1106
◽